By Dr Matthew Perry

Journal articles

Thorpe J; Perry MD; Contreras O; Hurley E; Parker G; Harvey RP; Hill AP; Vandenberg JI, 2023, 'Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia', Stem Cell Research and Therapy, 14, http://dx.doi.org/10.1186/s13287-023-03405-5

Lee W; Ng B; Mangala MM; Perry MD; Subbiah RN; Vandenberg JI; Hill AP, 2023, 'Action Potential Morphology Accurately Predicts Proarrhythmic Risk for Drugs with Potential to Prolong Cardiac Repolarization', Circulation: Arrhythmia and Electrophysiology, 16, pp. 399 - 410, http://dx.doi.org/10.1161/CIRCEP.122.011574

Shuttleworth JG; Lok Lei C; Windley M; Hill AP; Perry MD; Preston S; Mirams GR, 2023, 'Using many different voltage protocols to characterise discrepancy in mathematical ion channel models', Biophysical journal, 122, http://dx.doi.org/10.1016/j.bpj.2022.11.1415

TeBay C; McArthur JR; Mangala M; Kerr N; Heitmann S; Perry MD; Windley MJ; Vandenberg JI; Hill AP, 2022, 'Pathophysiological metabolic changes associated with disease modify the proarrhythmic risk profile of drugs with potential to prolong repolarisation', British Journal of Pharmacology, 179, pp. 2631 - 2646, http://dx.doi.org/10.1111/bph.15757

Ballouz S; Mangala MM; Perry MD; Heitmann S; Gillis JA; Hill AP; Vandenberg JI, 2021, 'Co-expression of calcium and hERG potassium channels reduces the incidence of proarrhythmic events', Cardiovascular Research, 117, pp. 2216 - 2227, http://dx.doi.org/10.1093/cvr/cvaa280

Ng CA; Farr J; Young P; Windley MJ; Perry MD; Hill AP; Vandenberg JI, 2021, 'Heterozygous KCNH2 variant phenotyping using Flp-In HEK293 and high-Throughput automated patch clamp electrophysiology', Biology Methods and Protocols, 6, pp. 1 - 9, http://dx.doi.org/10.1093/biomethods/bpab003

Ross S; Holliday M; Lim S; Mangala M; Perry M; Gray B; Fraser S; Hill A; Hudson J; Semsarian C, 2021, 'Functional Analysis of a Novel Heterozygous Variant in CASQ2 as a Distinct Cause of Catecholaminergic Polymorphic Ventricular Tachycardia', Heart, Lung and Circulation, 30, pp. S96 - S96, http://dx.doi.org/10.1016/j.hlc.2021.06.016

Ng C-A; Farr J; Young P; Windley M; Perry M; Hill A; Vandenberg J, 2021, 'HeterozygousKCNH2variant phenotyping using Flp-In HEK293 and high-throughput automated patch clamp electrophysiology', , http://dx.doi.org/10.1101/2021.02.02.427891

Perry MD; Ng CA; Mangala MM; Ng TYM; Hines AD; Liang W; Xu MJO; Hill AP; Vandenberg JI, 2020, 'Pharmacological activation of IKrin models of long QT Type 2 risks overcorrection of repolarization', Cardiovascular Research, 116, pp. 1434 - 1445, http://dx.doi.org/10.1093/cvr/cvz247

Ng CA; Perry MD; Liang W; Smith NJ; Foo B; Shrier A; Lukacs GL; Hill AP; Vandenberg JI, 2020, 'High-throughput phenotyping of heteromeric human ether-à-go-go-related gene potassium channel variants can discriminate pathogenic from rare benign variants', Heart Rhythm, 17, pp. 492 - 500, http://dx.doi.org/10.1016/j.hrthm.2019.09.020

Lee W; Windley MJ; Perry MD; Vandenberg JI; Hill AP, 2019, 'Protocol-dependent differences in IC50 values measured in human ether-á-go-go–related gene assays occur in a predictable way and can be used to quantify state preference of drug binding', Molecular Pharmacology, 95, pp. 537 - 550, http://dx.doi.org/10.1124/mol.118.115220

Lee W; Mangala M; Windley M; Perry M; Vandenberg J; Hill A, 2018, 'Novel Pre–Clinical Risk Prediction of Acquired Long QT Syndrome', Heart, Lung and Circulation, 27, pp. S180 - S180, http://dx.doi.org/10.1016/j.hlc.2018.06.309

Ng T; Vandenberg J; Perry M, 2018, 'Pharmacological Activation of hERG Potassium Channels in Congenital Long QT Syndrome 2: Activator Compound ICA-105574 and its Effects on Mutant hERG Potassium Channels in Long QT Syndrome 2', Heart, Lung and Circulation, 27, pp. S61 - S61, http://dx.doi.org/10.1016/j.hlc.2018.06.039

Phan K; Ng CA; David E; Shishmarev D; Kuchel PW; Vandenberg JI; Perry MD, 2017, 'The S1 helix critically regulates the finely tuned gating of Kv11.1 channels', Journal of Biological Chemistry, 292, pp. 7688 - 7705, http://dx.doi.org/10.1074/jbc.M117.779298

Vandenberg JI; Perry MD; Hill AP, 2017, 'Recent advances in understanding and prevention of sudden cardiac death', F1000Research, 6, http://dx.doi.org/10.12688/f1000research.11855.1

Hill AP; Perry MD; Abi-Gerges N; Couderc JP; Fermini B; Hancox JC; Knollmann BC; Mirams GR; Skinner J; Zareba W; Vandenberg JI, 2016, 'Computational cardiology and risk stratification for sudden cardiac death: one of the grand challenges for cardiology in the 21st century', Journal of Physiology, 594, pp. 6893 - 6908, http://dx.doi.org/10.1113/JP272015

Mann SA; Imtiaz M; Winbo A; Rydberg A; Perry MD; Couderc JP; Polonsky B; McNitt S; Zareba W; Hill AP; Vandenberg JI, 2016, 'Convergence of models of human ventricular myocyte electrophysiology after global optimization to recapitulate clinical long QT phenotypes', Journal of Molecular and Cellular Cardiology, 100, pp. 25 - 34, http://dx.doi.org/10.1016/j.yjmcc.2016.09.011

Ng CA; Gravel AE; Perry MD; Arnold AA; Marcotte I; Vandenberg JI, 2016, 'Tyrosine residues from the s4-s5 linker of kv11.1 channels are critical for slow deactivation', Journal of Biological Chemistry, 291, pp. 17293 - 17302, http://dx.doi.org/10.1074/jbc.M116.729392

Perry MD; Ng CA; Phan K; David E; Steer K; Hunter MJ; Mann SA; Imtiaz M; Hill AP; Ke Y; Vandenberg JI, 2016, 'Rescue of protein expression defects may not be enough to abolish the pro-arrhythmic phenotype of long QT type 2 mutations', Journal of Physiology, 594, pp. 4031 - 4049, http://dx.doi.org/10.1113/JP271805

Perry MD; Rajendran VM; MacLennan KA; Sandle GI, 2016, 'Segmental differences in upregulated apical potassium channels in Mammalian colon during potassium adaptation', American Journal of Physiology - Gastrointestinal and Liver Physiology, 311, pp. G785 - G793, http://dx.doi.org/10.1152/ajpgi.00181.2015

Perry MD; Vandenberg JI, 2016, 'TECRL: Connecting sequence to consequence for a new sudden cardiac death gene', EMBO Molecular Medicine, 8, pp. 1364 - 1365, http://dx.doi.org/10.15252/emmm.201606967

Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H, 2015, 'A universal and robust integrated platform for the scalable production of human cardiomyocytes from pluripotent stem cells', Stem Cells Translational Medicine, 4, pp. 1482 - 1494, http://dx.doi.org/10.5966/sctm.2014-0275

Perry MD; Ng CA; Mann SA; Sadrieh A; Imtiaz M; Hill AP; Vandenberg JI, 2015, 'Getting to the heart of hERG K⁺ channel gating', Journal of Physiology, 593, pp. 2575 - 2585, http://dx.doi.org/10.1113/JP270095

Brignell JL; Perry MD; Nelson CP; Willets JM; Challiss RAJ; Davies NW, 2015, 'Steady-state modulation of voltage-gated K⁺ channels in rat arterial smooth muscle by cyclic AMP-dependent protein kinase and protein phosphatase 2B', PLoS ONE, 10, http://dx.doi.org/10.1371/journal.pone.0121285

Vandenberg JI; Perry MD, 2014, 'Can many subunits make light work of ion channel inactivation?', Journal of Physiology, 592, pp. 4411 - 4412, http://dx.doi.org/10.1113/jphysiol.2014.281568

Ng CA; Phan K; Hill AP; Vandenberg JI; Perry MD, 2014, 'Multiple interactions between cytoplasmic domains regulate slow deactivation of Kv11.1 channels', Journal of Biological Chemistry, 289, pp. 25822 - 25832, http://dx.doi.org/10.1074/jbc.M114.558379

Ke Y; Hunter MJ; Ng CA; Perry MD; Vandenberg JI, 2014, 'Role of the cytoplasmic N-terminal cap and Per-Arnt-Sim (PAS) domain in trafficking and stabilization of Kv11.1 channels', Journal of Biological Chemistry, 289, pp. 13782 - 13791, http://dx.doi.org/10.1074/jbc.M113.531277

Sadrieh A; Domanski L; Pitt-Francis J; Mann SA; Hodkinson EC; Ng CA; Perry MD; Taylor JA; Gavaghan D; Subbiah RN; Vandenberg JI; Hill AP, 2014, 'Multiscale cardiac modelling reveals the origins of notched T waves in long QT syndrome type 2', Nature Communications, 5, http://dx.doi.org/10.1038/ncomms6069

Ng CA; Ke Y; Perry MD; Tan PS; Hill AP; Vandenberg JI, 2013, 'C-Terminal β9-Strand of the Cyclic Nucleotide-Binding Homology Domain Stabilizes Activated States of Kv11.1 Channels', PLoS ONE, 8, pp. e77032, http://dx.doi.org/10.1371/journal.pone.0077032

Perry MD; Wong S; Ng CA; Vandenberg JI, 2013, 'Hydrophobic interactions between the voltage sensor and pore mediate inactivation in Kv11.1 channels', Journal of General Physiology, 142, pp. 275 - 288, http://dx.doi.org/10.1085/jgp.201310975

Tan PS; Perry MD; Ng C; Vandenberg JI; Hill A, 2012, 'Voltage-sensing domain mode shift is coupled to the activation gate by the N-terminal tail of hERG channels', Journal of General Physiology, 140, pp. 293 - 306, http://dx.doi.org/10.1085/jgp.201110761

Nelson CP; Rainbow RD; Brignell JL; Perry MD; Willets JM; Davies NW; Standen NB; Challiss RAJ, 2011, 'Principal role of adenylyl cyclase 6 in K ⁺ channel regulation and vasodilator signalling in vascular smooth muscle cells', Cardiovascular Research, 91, pp. 694 - 702, http://dx.doi.org/10.1093/cvr/cvr137

Perry M; Sanguinetti M; Mitcheson J, 2010, 'Revealing the structural basis of action of hERG potassium channel activators and blockers', Journal of Physiology, 588, pp. 3157 - 3167, http://dx.doi.org/10.1113/jphysiol.2010.194670

Perry M; Sachse FB; Abbruzzese J; Sanguinetti MC, 2009, 'PD-118057 contacts the pore helix of hERG1 channels to attenuate inactivation and enhance K⁺ conductance', Proceedings of the National Academy of Sciences of the United States of America, 106, pp. 20075 - 20080, http://dx.doi.org/10.1073/pnas.0906597106

Perry MD; Sandle GI, 2009, 'Regulation of colonic apical potassium (BK) channels by cAMP and somatostatin', American Journal of Physiology - Gastrointestinal and Liver Physiology, 297, http://dx.doi.org/10.1152/ajpgi.00132.2009

Perry M; Sanguinetti MC, 2008, 'A single amino acid difference between ether-a-go-go-related gene channel subtypes determines differential sensitivity to a small molecule activator', Molecular Pharmacology, 73, pp. 1044 - 1051, http://dx.doi.org/10.1124/mol.107.043018

Perry M; Sachse FB; Sanguinetti MC, 2007, 'Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator', Proceedings of the National Academy of Sciences of the United States of America, 104, pp. 13827 - 13832, http://dx.doi.org/10.1073/pnas.0703934104

Sandle GI; Perry MD; Mathialahan T; Linley JE; Robinson P; Hunter M; MacLennan KA, 2007, 'Altered cryptal expression of luminal potassium (BK) channels in ulcerative colitis', Journal of Pathology, 212, pp. 66 - 73, http://dx.doi.org/10.1002/path.2159

Perry M; Stansfeld PJ; Leaney J; Wood C; De Groot MJ; Leishman D; Sutcliffe MJ; Mitcheson JS, 2006, 'Drug binding interactions in the inner cavity of hERG channels: Molecular insights from structure-activity relationships of clofilium and ibutilide analogs', Molecular Pharmacology, 69, pp. 509 - 519, http://dx.doi.org/10.1124/mol.105.016741

Witchel HJ; Dempsey CE; Sessions RB; Perry M; Milnes JT; Hancox JC; Mitcheson JS, 2004, 'The low-potency, voltage-dependent herg blocker propafenone - Molecular determinants and drug trapping', Molecular Pharmacology, 66, pp. 1201 - 1212, http://dx.doi.org/10.1124/mol.104.001743

Perry M; De Groot MJ; Helliwell R; Leishman D; Tristani-Firouzi M; Sanguinetti MC; Mitcheson J, 2004, 'Structural determinants of HERG channel block by clofilium and ibutilide', Molecular Pharmacology, 66, pp. 240 - 249, http://dx.doi.org/10.1124/mol.104.000117

Mitcheson JS; Perry MD, 2003, 'Molecular determinants of high-affinity drug binding to HERG channels', Current Opinion in Drug Discovery and Development, 6, pp. 667 - 674

Back to profile page